Every day your ads are off is costing the practice A$4,412 in accepted treatment plans.

Why we are reaching out.

Your April retainer has not yet cleared and, as a result, the Meta and Google campaigns came off on Tuesday morning. This was standard protocol for unpaid retainers, but we are concerned that what the pause is doing to your new patient pipeline is not visible to you yet.

We pulled your numbers together across your four source systems, patient by patient, so every figure in this report ties directly back to data you already hold. The numbers below are not an estimate, they are your own records.

A$7,000 saved. A$132,353 lost.

If the invoice remains unpaid for the full month, the practice will have avoided a A$7,000 retainer cost and lost a projected A$132,353 in accepted treatment value. That is not ad spend, that is accepted patient revenue that would otherwise have landed in Core Practice.

For every A$1 spent, A$11 comes back.

February 2026 is the month we reconciled in full. 83 new patient records from Core Practice, matched by mobile number against Meta and Google Ads lead forms and against your GHL contact records. Here is what those 83 patients actually did.

A$130,044 in ad spend. A$2.35M in collections.

This is not a February story. Across the last nine months the practice has returned A$18 in collections for every A$1 spent on ads, month after month.

A$57.9M of warm pipeline depends on the ads staying on.

Your GHL pipeline currently holds A$57.9M in qualified open patient opportunities. A$13.6M of that sits in active nurture, which means patients who have already attended a consultation, already received a treatment plan, and are being followed up until they commit.

Every one of those nurture patients exists because the ads put them into the pipeline. The ads are also what keeps the pipeline refilled. When they are paused, no new high-intent patients enter the funnel, and three to six months from now the practice will feel the gap in converted revenue.

One new patient is not one treatment.

The opportunity cost numbers above only count the first treatment plan each new patient accepts. They do not count the second, third, or fourth treatment that same patient comes back for. That is where the real number lives.

The moment the invoice clears, we relaunch the same day.

Clearing the A$7,000 retainer puts Meta and Google back live within 24 hours. Leadflow starts rebuilding immediately across Bondi Junction and North Sydney. Account access stays exactly where it is.

How every number in this report was sourced.

Every claim in this document is auditable against your own records. Here is the exact source and field for each data layer, so you can reconcile any number against the system it came from.

• Core Practice Source of truth for attendance, treatment plans presented, treatment plans accepted, and accepted treatment value. 83 February 2026 new patient records exported and matched on mobile field. Fields used: Attendance, Tx Plan Presented, Tx Plan Accepted, Tx Value, Referral Source, Location.
• Meta Ads Manager (live API) Source of truth for ad spend, impressions, reach, CPL, and lead volume. Account: Smile by Design 2.0 (act_728654235373274). Six active campaigns reconciled across the full account history, with daily spend and lead volume pulled for the trailing 90 days for the opportunity cost model.
• Google Ads Source of truth for Google paid search spend and lead volume. Monthly spend and lead counts pulled from Smile by Design's Google Ads dashboard, reconciled against GHL contact tags to identify Google-sourced patients.
• GoHighLevel CRM (private integration) Source of truth for open pipeline value, nurture status, and treatment type tagging. 10,000 opportunity records pulled via private integration API. Location: iA6Um8A9NDsrtgeeK4L3. Filters: status = open, monetaryValue > 0, tag = sent_to_nurture.
• Opportunity cost model February 2026 Core Practice conversion rates (80% show, 65% presentation, 57% acceptance on paid leads) applied to the trailing 90-day average daily ad spend and lead volume from Meta and Google. Conservative. Excludes the nurture pipeline LTV. No projections on untested growth.